相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review
Vikas Soekhai et al.
DRUG DISCOVERY TODAY (2019)
Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial
Giorgio V. Scagliotti et al.
LANCET RESPIRATORY MEDICINE (2019)
The Value of Progression-Free Survival as a Treatment End Point Among Patients With Advanced Cancer A Systematic Review and Qualitative Assessment of the Literature
Michael J. Raphael et al.
JAMA ONCOLOGY (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
First- and Second-Generation EGFR-TKIs Are All Replaced to Osimertinib in Chemo-Naive EGFR Mutation-Positive Non-Small Cell Lung Cancer?
Masayuki Takeda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Discrete Choice Experiments in Health Economics: Past, Present and Future
Vikas Soekhai et al.
PHARMACOECONOMICS (2019)
How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an Event
John F. P. Bridges et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2019)
Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review
Mo Zhou et al.
PHARMACOECONOMICS (2018)
Project Transform: engaging patient advocates to share their perspectives on improving research, treatment and policy
John F. P. Bridges et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices: An Application for Eliciting Patient Preferences for Diabetes Treatments.
Ellen M. Janssen et al.
VALUE IN HEALTH (2018)
Effect of Level Overlap and Color Coding on Attribute Non-Attendance in Discrete Choice Experiments
Marcel F. Jonker et al.
VALUE IN HEALTH (2018)
Research as an event: a novel approach to promote patient-focused drug development
Jui-Hua Tsai et al.
PATIENT PREFERENCE AND ADHERENCE (2018)
A consensus on the role of osimertinib in non-small cell lung cancer from the AME Lung Cancer Collaborative Group
Tao Jiang et al.
JOURNAL OF THORACIC DISEASE (2018)
Education and patient preferences for treating type 2 diabetes: a stratified discrete-choice experiment
Ellen M. Janssen et al.
PATIENT PREFERENCE AND ADHERENCE (2017)
Preferences of lung cancer patients for treatment and decision-making: a systematic literature review
K. Schmidt et al.
EUROPEAN JOURNAL OF CANCER CARE (2016)
Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force
A. Brett Hauber et al.
VALUE IN HEALTH (2016)
Patient Preferences in Regulatory Benefit-Risk Assessments: A US Perspective
F. Reed Johnson et al.
VALUE IN HEALTH (2016)
A Framework for Instrument Development of a Choice Experiment: An Application to Type 2 Diabetes
Ellen M. Janssen et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2016)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Emerging treatments and combinations in the management of NSCLC: clinical potential of nintedanib
Martin Reck et al.
BIOLOGICS-TARGETS & THERAPY (2015)
Patients' preferences: a discrete-choice experiment for treatment of non-small-cell lung cancer
Axel C. Muehlbacher et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2015)
Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Ethan Basch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
Benjamin J. Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Discrete Choice Experiments in Health Economics: A Review of the Literature
Michael D. Clark et al.
PHARMACOECONOMICS (2014)
Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force
F. Reed Johnson et al.
VALUE IN HEALTH (2013)
Discrete choice experiments in health economics: a review of the literature
Esther W. de Bekker-Grob et al.
HEALTH ECONOMICS (2012)
Patients' preferences for treatment outcomes for advanced non-small cell lung cancer: A conjoint analysis
John F. P. Bridges et al.
LUNG CANCER (2012)
Can scale and coefficient heterogeneity be separated in random coefficients models?
Stephane Hess et al.
TRANSPORTATION (2012)
Mixed logit estimation of willingness to pay distributions: a comparison of models in preference and WTP space using data from a health-related choice experiment
Arne Risa Hole et al.
EMPIRICAL ECONOMICS (2012)
Conjoint Analysis Applications in Health-a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force
John F. P. Bridges et al.
VALUE IN HEALTH (2011)
Can Patients Diagnosed with Schizophrenia Complete Choice-Based Conjoint Analysis Tasks?
John F. P. Bridges et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2011)
Estimating importance weights for the IWQOL-Lite using conjoint analysis
A. Brett Hauber et al.
QUALITY OF LIFE RESEARCH (2010)
Using Conjoint Analysis to Estimate Healthy-Year Equivalents for Acute Conditions: An Application to Vasomotor Symptoms
F. Reed Johnson et al.
VALUE IN HEALTH (2009)
Utility in willingness to pay space: A tool to address confounding random scale effects in destination choice to the Alps
Riccardo Scarpa et al.
AMERICAN JOURNAL OF AGRICULTURAL ECONOMICS (2008)
A comparison of approaches to estimating confidence intervals for willingness to pay measures
Arne Risa Hole
HEALTH ECONOMICS (2007)
分享论文
